Latest Obesity News

Restaurant critic's departure reveals potential hazards of the job

Jul. 21, 2024 06:44 AM EDT

Restaurant critics appear to have the best job in journalism, enjoying meals a few nights a week on someone else’s dime. But New York Times restaurant critic Pete Wells had painted a more complicated picture. In a recent column, Wells announced he’s leaving the beat because the...

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

Jun. 21, 2024 18:21 PM EDT

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea...

Is intermittent fasting better than counting calories? Maybe not, but you might stick with it

Jun. 01, 2024 12:44 PM EDT

As weight-loss plans go, it’s easy to see the allure of intermittent fasting: Eat what you want, but only during certain windows of time — often just eight hours a day. Instead of counting calories or measuring portions, dieters just have to pay attention to the clock, said...

So you've lost weight using Wegovy. Does that mean you can stop taking it?

May. 01, 2024 14:30 PM EDT

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll regain weight and revert to old habits. In studies, people who paused the drugs...

Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues

Apr. 30, 2024 12:19 PM EDT

Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street's expectations even as it hustles...